Full Text (PDF)
Original Article

Role of Pleural Fluid ADA & the Combination tests in Tubercular Pleural Effusion

Akshata J.S , Akshata J.S , Manjunath K.N.

Author Information

Licence:



Indian Journal of Pathology: Research and Practice 1(3):p 123-130, . | DOI:
How Cite This Article:

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Tuberculosis is an oldest and common infectious disease. Detected as far back as 10,000 BC it still remains a major public health problem world wide The use of biological markers in the diagnosis of tuberculous pleural effusion (TPE) is a breakthrough Adenosine deaminase(ADA) has been proposed to be a useful surrogate marker for TB in pleural, peritoneal and pericardial fluids. Although sensitive it is not a specific diagnostic tool, but combined with other tests the sensitivity can be increased. Materials&methods; 100 patients of suspected TPE were studied .Sensitivity and specificity of pleural fluid ADA alone and in combination with Mantoux test, pleural fluid cytology studied. Conclusion; pleural fluid ADA (>63U/L) alone was essentially diagnostic of TPE, between 40-63U/L it is highly suspicious of TPE along with >50% lymphocytes in pleural fluid confirms the diagnosis.

Keywords: Tubercular pleural effusion; ADA; Mantoux test; Pleural fluid cytology.  


References

No records found.


Funding


Author Information

Authors and Affiliatione

  • Akshata J.S
    ,
  • Akshata J.S
    ,
  • Manjunath K.N.
    ,

Conflicts of Interest

Supplementary Information

Below is the link to the supplementary material.


Rights and Permissions



About this article


Cite this article


Licence:



Download citation

Received Accepted Published
N/A N/A N/A
DOI:
Keywords

Article Level Metrics

Last Updated

Sunday 08 June 2025, 02:06:09 (IST)


4

Accesses

00
0
00

Citations


22
11
23

View full article metrics including social shares, article views and publishing history


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article




Share